Goal-directed therapy based on rScO2 monitoring in elderly patients with one-lung ventilation: a randomized trial on perioperative inflammation and postoperative delirium

ConclusionGoal-directed therapy based on rScO2 monitoring can reduce perioperative inflammatory factor levels, postoperative delirium incidence, and postoperative awakening time and improve tissue perfusion in elderly patients with one-lung ventilation.Trial registrationThe Chinese Clinical Trial RegistryChiCTR2100054888. Registered on 28 December 2021
Source: Trials - Category: Research Source Type: clinical trials